US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Theriva Biologics

0.2400

+0.00502.13%

Volume:78.29K

Turnover:18.40K

Market Cap:11.01M

PE:-0.35

High:0.2400

Open:0.2364

Low:0.2330

Close:0.2350

52wk High:0.8632

52wk Low:0.1628

Shares:45.89M

Float Shares:45.14M

Volume Ratio:0.85

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6904

EPS(LYR):-2.0797

ROE:-101.87%

ROA:-21.34%

PB:0.90

PE(LYR):-0.12

Loading ...

Overview Company News Filings

Inovio Q2 Net Loss Narrows on Warrant Gain, Lower Costs

HC Wainwright Starts Theriva (TOVX) at Buy on Undervalued Oncolytic Virus Platform and Advancing VCN-01 Pancreatic Cancer Program

Cardiff Oncology Q2 Operating Expenses Fall on Lower R&D Costs

Bolt Biotherapeutics Q2 Net Loss Narrows on Restructuring and Lower Research Activity

Theriva Biologics Q2 EPS $(0.07) Misses $(0.05) Estimate

Benzinga Earnings

Theriva Biologics Q2 Net Income USD -3.217 Million

Theriva™ Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results

THOMSON REUTERS

Theriva Biologics Q2 EPS USD -0.07

THOMSON REUTERS

Press Release: Theriva(TM) Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results

Theriva Biologics Doses First Patient in Virage2 Phase 2a Trial of VCN-01 for Metastatic Pancreatic Cancer

Theriva Biologics Holds Annual Shareholder Meeting

Theriva Biologics Wins Spanish Regulator Clearance for Virage2 Vcn-01 Pancreatic Cancer Trial

Theriva™ Biologics Announces Regulatory Authorization to Proceed with a Virage2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of Vcn-01 (zabilugene Almadenorepvec) in First-line Patients with Metastatic Pancreatic Ductal Adenocarcinoma

THOMSON REUTERS

Theriva Biologics reports Phase 1 data showing VCN-01 plus durvalumab extends survival in refractory head and neck cancer

Theriva Biologics - Median Overall Survival Reached 17.3 Months in Arm Ii Hd of Vcn-1 Phase 1 Trial

THOMSON REUTERS

Theriva Biologics - Prolonged Overall Survival Observed in Refractory Hnscc Patients With Vcn-1 and Durvalumab

THOMSON REUTERS

Theriva™ Biologics Announces Results From Vcn-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research

THOMSON REUTERS

Theriva Biologics Faces Quorum Issue Delaying Warrant Vote

Alliance Global Partners Sticks to Its Buy Rating for Theriva Biologics (TOVX)

Theriva Biologics Q1 FY26 net loss narrows to $2 million; revenue rises to $300,000

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TOVX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TOVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TOVX\",,,,,undefined,":{"symbol":"TOVX","market":"US","secType":"STK","nameCN":"Theriva Biologics","latestPrice":0.24,"timestamp":1787581942760,"preClose":0.235,"halted":0,"volume":78290,"delay":0,"changeRate":0.02127659574468087,"floatShares":45143400,"shares":45892668,"eps":-0.6904,"marketStatus":"Trading","change":0.005,"latestTime":"08-24 10:34:27 EDT","open":0.2364,"high":0.24,"low":0.233,"amount":18401.5297793,"amplitude":0.029787,"askPrice":0.2574,"askSize":1900,"bidPrice":0.2169,"bidSize":1900,"shortable":3,"etf":0,"ttmEps":-0.6904,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"exchange":"AMEX","adjPreClose":0.235,"preHourTrading":{"tag":"盘前","latestPrice":0.2398,"preClose":0.235,"latestTime":"09:21 EDT","volume":21453,"amount":5118.9368001,"timestamp":1787577660466,"change":0.0048,"changeRate":0.020426,"amplitude":0.039574},"postHourTrading":{"tag":"盘后","latestPrice":0.2312,"preClose":0.235,"latestTime":"19:48 EDT","volume":10339,"amount":2452.5739,"timestamp":1787356104620,"change":-0.0038,"changeRate":-0.01617,"amplitude":0.036596},"volumeRatio":0.850272},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TOVX\",,,,,undefined,":{"symbol":"TOVX","floatShares":45143400,"roa":"-21.34%","roe":"-101.87%","lyrEps":-2.079699,"volumeRatio":0.850272,"shares":45892668,"dividePrice":0,"high":0.24,"amplitude":0.029787,"preClose":0.235,"low":0.233,"week52Low":0.1628,"pbRate":"0.90","psRate":"36.71","week52High":0.8632,"institutionHeld":0.0983,"latestPrice":0.24,"eps":-0.6904,"divideRate":0,"volume":78290,"delay":0,"ttmEps":-0.6904,"open":0.2364,"prevYearClose":0.2104,"prevWeekClose":0.235,"prevMonthClose":0.21,"prevQuarterClose":0.2502,"fiveDayClose":0.2376,"twentyDayClose":0.213,"sixtyDayClose":0.309},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TOVX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"TOVX","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2026-05-05","symbol":"TOVX","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":-0.05},{"date":"2026-03-12","symbol":"TOVX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":null,"defaultRemindTime":1773302400000,"name":null,"time":"Pre-MKt","dateTimestamp":1773288000000,"actualEps":null},{"market":"US","date":"2025-11-12","symbol":"TOVX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-08-11","symbol":"TOVX","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-1.93}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TOVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TOVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1775016000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TOVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TOVX","date":"2026-08-21","current":-0.340382,"percent":0.235102,"low":-6.845814,"twenty":-1.363639,"median":-0.448751,"eighty":-0.161746,"high":-0.056131,"avg":-1.032044,"sd":1.461085,"marketCap":10564492},"quantilePoints":[{"date":"2021-08-27","current":-6.452727,"twenty":-3.130706,"median":-0.729547,"eighty":-0.542403,"marketCap":64159465},{"date":"2021-09-03","current":-6.726294,"twenty":-3.178396,"median":-0.729686,"eighty":-0.542403,"marketCap":66879541},{"date":"2021-09-10","current":-6.798006,"twenty":-3.194253,"median":-0.732303,"eighty":-0.542403,"marketCap":67592571},{"date":"2021-09-17","current":-6.382343,"twenty":-3.213982,"median":-0.741153,"eighty":-0.542537,"marketCap":63459639},{"date":"2021-09-24","current":-6.566935,"twenty":-3.278986,"median":-0.742349,"eighty":-0.54297,"marketCap":65295031},{"date":"2021-10-01","current":-6.030425,"twenty":-3.304661,"median":-0.747481,"eighty":-0.543109,"marketCap":59960512},{"date":"2021-10-08","current":-5.617418,"twenty":-3.334322,"median":-0.752374,"eighty":-0.543701,"marketCap":55853990},{"date":"2021-10-15","current":-5.772794,"twenty":-3.345181,"median":-0.752851,"eighty":-0.544169,"marketCap":57398887},{"date":"2021-10-22","current":-5.391659,"twenty":-3.400752,"median":-0.754125,"eighty":-0.544316,"marketCap":53609267},{"date":"2021-10-29","current":-5.492587,"twenty":-3.745956,"median":-0.764317,"eighty":-0.544913,"marketCap":54612790},{"date":"2021-11-05","current":-4.992736,"twenty":-4.551182,"median":-0.764433,"eighty":-0.545058,"marketCap":55484271},{"date":"2021-11-12","current":-4.65054,"twenty":-4.730623,"median":-0.768317,"eighty":-0.546509,"marketCap":51681446},{"date":"2021-11-19","current":-4.277451,"twenty":-4.687373,"median":-0.770925,"eighty":-0.546872,"marketCap":47535310},{"date":"2021-11-26","current":-4.063578,"twenty":-4.671179,"median":-0.774385,"eighty":-0.547752,"marketCap":45158545},{"date":"2021-12-03","current":-3.680984,"twenty":-4.657329,"median":-0.786323,"eighty":-0.548571,"marketCap":40906775},{"date":"2021-12-10","current":-3.868717,"twenty":-4.641812,"median":-0.787309,"eighty":-0.548963,"marketCap":42993047},{"date":"2021-12-17","current":-3.847329,"twenty":-4.627611,"median":-0.788987,"eighty":-0.549663,"marketCap":42755371},{"date":"2021-12-23","current":-3.938225,"twenty":-4.585205,"median":-0.79918,"eighty":-0.550108,"marketCap":43765496},{"date":"2021-12-31","current":-3.234228,"twenty":-4.516893,"median":-0.803705,"eighty":-0.55026,"marketCap":35941976},{"date":"2022-01-07","current":-3.301954,"twenty":-4.470466,"median":-0.810762,"eighty":-0.551195,"marketCap":36694619},{"date":"2022-01-14","current":-3.132044,"twenty":-4.416951,"median":-0.818396,"eighty":-0.552757,"marketCap":34806410},{"date":"2022-01-21","current":-2.977581,"twenty":-4.382338,"median":-0.823792,"eighty":-0.553146,"marketCap":33089858},{"date":"2022-01-28","current":-2.756579,"twenty":-4.314522,"median":-0.839718,"eighty":-0.55352,"marketCap":30633866},{"date":"2022-02-04","current":-2.817177,"twenty":-4.277451,"median":-0.860023,"eighty":-0.554015,"marketCap":31307283},{"date":"2022-02-11","current":-3.114222,"twenty":-4.269229,"median":-0.879323,"eighty":-0.554319,"marketCap":34608347},{"date":"2022-02-18","current":-3.003721,"twenty":-4.232683,"median":-0.896124,"eighty":-0.554405,"marketCap":33380351},{"date":"2022-02-25","current":-2.82787,"twenty":-4.218042,"median":-0.920532,"eighty":-0.554406,"marketCap":31426122},{"date":"2022-03-04","current":-2.881338,"twenty":-4.112294,"median":-0.956767,"eighty":-0.555309,"marketCap":32020313},{"date":"2022-03-11","current":-2.825494,"twenty":-4.099224,"median":-1.006209,"eighty":-0.555502,"marketCap":31399713},{"date":"2022-03-18","current":-4.775235,"twenty":-4.099224,"median":-1.037737,"eighty":-0.556101,"marketCap":68128271},{"date":"2022-03-25","current":-3.919024,"twenty":-4.099224,"median":-1.064779,"eighty":-0.556465,"marketCap":55912713},{"date":"2022-04-01","current":-3.194965,"twenty":-4.099224,"median":-1.08458,"eighty":-0.556893,"marketCap":45582566},{"date":"2022-04-08","current":-2.887351,"twenty":-4.063578,"median":-1.094696,"eighty":-0.558899,"marketCap":41193838},{"date":"2022-04-14","current":-2.942877,"twenty":-4.016051,"median":-1.111061,"eighty":-0.559105,"marketCap":41986027},{"date":"2022-04-22","current":-2.709668,"twenty":-3.997515,"median":-1.129172,"eighty":-0.559519,"marketCap":38658832},{"date":"2022-04-29","current":-2.653031,"twenty":-3.983495,"median":-1.139179,"eighty":-0.560037,"marketCap":37850799},{"date":"2022-05-06","current":-2.724105,"twenty":-3.949038,"median":-1.14331,"eighty":-0.560197,"marketCap":38864802},{"date":"2022-05-13","current":-2.54309,"twenty":-3.938819,"median":-1.151205,"eighty":-0.560273,"marketCap":36282265},{"date":"2022-05-20","current":-2.161146,"twenty":-3.926343,"median":-1.156529,"eighty":-0.56058,"marketCap":34586980},{"date":"2022-05-27","current":-2.159166,"twenty":-3.919894,"median":-1.156897,"eighty":-0.561617,"marketCap":34555292},{"date":"2022-06-03","current":-2.133426,"twenty":-3.909696,"median":-1.165802,"eighty":-0.56225,"marketCap":34143354},{"date":"2022-06-10","current":-2.078977,"twenty":-3.896879,"median":-1.16828,"eighty":-0.56264,"marketCap":33271946},{"date":"2022-06-17","current":-1.864149,"twenty":-3.879648,"median":-1.175074,"eighty":-0.563105,"marketCap":29833845},{"date":"2022-06-24","current":-1.918599,"twenty":-3.870143,"median":-1.182994,"eighty":-0.563591,"marketCap":30705253},{"date":"2022-07-01","current":-2.276975,"twenty":-3.861743,"median":-1.193251,"eighty":-0.564291,"marketCap":36440703},{"date":"2022-07-08","current":-2.351224,"twenty":-3.850491,"median":-1.193434,"eighty":-0.56495,"marketCap":37628987},{"date":"2022-07-15","current":-1.613682,"twenty":-3.844122,"median":-1.200778,"eighty":-0.565523,"marketCap":25825367},{"date":"2022-07-22","current":-1.534483,"twenty":-3.830182,"median":-1.211611,"eighty":-0.565679,"marketCap":24557865},{"date":"2022-07-29","current":-1.425584,"twenty":-3.824355,"median":-1.222168,"eighty":-0.565726,"marketCap":22815048},{"date":"2022-08-05","current":-1.435484,"twenty":-3.815486,"median":-1.229972,"eighty":-0.566106,"marketCap":22973486},{"date":"2022-08-12","current":-1.310163,"twenty":-3.80099,"median":-1.231807,"eighty":-0.567168,"marketCap":23290769},{"date":"2022-08-19","current":-1.336901,"twenty":-3.796,"median":-1.248516,"eighty":-0.56839,"marketCap":23766091},{"date":"2022-08-26","current":-1.354726,"twenty":-3.791193,"median":-1.256699,"eighty":-0.568728,"marketCap":24082972},{"date":"2022-09-02","current":-1.283425,"twenty":-3.766883,"median":-1.265958,"eighty":-0.568978,"marketCap":22815447},{"date":"2022-09-09","current":-1.274512,"twenty":-3.731346,"median":-1.2656,"eighty":-0.569201,"marketCap":22657007},{"date":"2022-09-16","current":-1.194298,"twenty":-3.702371,"median":-1.258398,"eighty":-0.569382,"marketCap":21231041},{"date":"2022-09-23","current":-0.944743,"twenty":-3.68336,"median":-1.248516,"eighty":-0.571834,"marketCap":16794704},{"date":"2022-09-30","current":-0.87879,"twenty":-3.680984,"median":-1.247774,"eighty":-0.572488,"marketCap":15622244},{"date":"2022-10-07","current":-0.944743,"twenty":-3.623359,"median":-1.238862,"eighty":-0.572707,"marketCap":16794704},{"date":"2022-10-14","current":-0.882444,"twenty":-3.598084,"median":-1.230155,"eighty":-0.573146,"marketCap":15687204},{"date":"2022-10-21","current":-0.819966,"twenty":-3.578801,"median":-1.229949,"eighty":-0.574242,"marketCap":14576536},{"date":"2022-10-28","current":-0.677363,"twenty":-3.562166,"median":-1.222168,"eighty":-0.575776,"marketCap":12041486},{"date":"2022-11-04","current":-0.643941,"twenty":-3.550284,"median":-1.211611,"eighty":-0.57763,"marketCap":11447334},{"date":"2022-11-11","current":-0.504821,"twenty":-3.533232,"median":-1.20188,"eighty":-0.575776,"marketCap":9771824},{"date":"2022-11-18","current":-0.572963,"twenty":-3.505133,"median":-1.198208,"eighty":-0.572707,"marketCap":11090842},{"date":"2022-11-25","current":-0.570917,"twenty":-3.42425,"median":-1.193434,"eighty":-0.571651,"marketCap":11051232},{"date":"2022-12-02","current":-0.589333,"twenty":-3.403021,"median":-1.191874,"eighty":-0.572357,"marketCap":11407723},{"date":"2022-12-09","current":-0.487591,"twenty":-3.400752,"median":-1.177694,"eighty":-0.569346,"marketCap":9438307},{"date":"2022-12-16","current":-0.459925,"twenty":-3.391351,"median":-1.174155,"eighty":-0.56803,"marketCap":8902777},{"date":"2022-12-23","current":-0.328234,"twenty":-3.388948,"median":-1.165893,"eighty":-0.56564,"marketCap":6353618},{"date":"2022-12-30","current":-0.355345,"twenty":-3.385925,"median":-1.16571,"eighty":-0.563708,"marketCap":6878422},{"date":"2023-01-06","current":-0.453167,"twenty":-3.379661,"median":-1.156529,"eighty":-0.561376,"marketCap":8771955},{"date":"2023-01-13","current":-0.531221,"twenty":-3.359732,"median":-1.147716,"eighty":-0.55993,"marketCap":10282849},{"date":"2023-01-20","current":-0.59693,"twenty":-3.359732,"median":-1.138353,"eighty":-0.55993,"marketCap":11554782},{"date":"2023-01-27","current":-0.707096,"twenty":-3.331421,"median":-1.101632,"eighty":-0.55993,"marketCap":13687260},{"date":"2023-02-03","current":-0.836015,"twenty":-3.315024,"median":-1.078434,"eighty":-0.55993,"marketCap":16182745},{"date":"2023-02-10","current":-0.812575,"twenty":-3.315024,"median":-1.037737,"eighty":-0.55993,"marketCap":15729023},{"date":"2023-02-17","current":-0.764758,"twenty":-3.315024,"median":-1.016045,"eighty":-0.55993,"marketCap":14803430},{"date":"2023-02-24","current":-0.735225,"twenty":-3.315024,"median":-0.956767,"eighty":-0.55993,"marketCap":14231741},{"date":"2023-03-03","current":-0.673813,"twenty":-3.305797,"median":-0.938905,"eighty":-0.55993,"marketCap":13042990},{"date":"2023-03-10","current":-0.578179,"twenty":-3.302932,"median":-0.918451,"eighty":-0.55993,"marketCap":11191820},{"date":"2023-03-17","current":-0.593805,"twenty":-3.289122,"median":-0.901567,"eighty":-0.55993,"marketCap":11494286},{"date":"2023-03-24","current":-0.483561,"twenty":-3.289122,"median":-0.880893,"eighty":-0.55886,"marketCap":9360281},{"date":"2023-03-31","current":-0.536583,"twenty":-3.284844,"median":-0.860364,"eighty":-0.555981,"marketCap":10562644},{"date":"2023-04-06","current":-0.537736,"twenty":-3.284844,"median":-0.849689,"eighty":-0.554406,"marketCap":10585330},{"date":"2023-04-14","current":-0.545496,"twenty":-3.289122,"median":-0.836015,"eighty":-0.553272,"marketCap":10738083},{"date":"2023-04-21","current":-0.545496,"twenty":-3.289122,"median":-0.822344,"eighty":-0.552002,"marketCap":10738083},{"date":"2023-04-28","current":-0.50831,"twenty":-3.289122,"median":-0.816188,"eighty":-0.548963,"marketCap":10006078},{"date":"2023-05-05","current":-0.560862,"twenty":-3.289122,"median":-0.805845,"eighty":-0.546872,"marketCap":11040564},{"date":"2023-05-12","current":-0.529208,"twenty":-3.289122,"median":-0.789136,"eighty":-0.546322,"marketCap":10417453},{"date":"2023-05-19","current":-0.539873,"twenty":-3.289122,"median":-0.786548,"eighty":-0.545058,"marketCap":10738083},{"date":"2023-05-26","current":-0.504896,"twenty":-3.289122,"median":-0.771626,"eighty":-0.543556,"marketCap":10042376},{"date":"2023-06-02","current":-0.485962,"twenty":-3.293399,"median":-0.76666,"eighty":-0.54247,"marketCap":9665787},{"date":"2023-06-08","current":-0.533866,"twenty":-3.297677,"median":-0.764433,"eighty":-0.542403,"marketCap":10618603},{"date":"2023-06-16","current":-0.53227,"twenty":-3.301954,"median":-0.758263,"eighty":-0.540326,"marketCap":10586842},{"date":"2023-06-23","current":-0.502158,"twenty":-3.303142,"median":-0.752851,"eighty":-0.538322,"marketCap":9987929},{"date":"2023-06-30","current":-0.699554,"twenty":-3.30433,"median":-0.747625,"eighty":-0.537275,"marketCap":13914136},{"date":"2023-07-07","current":-0.623592,"twenty":-3.30433,"median":-0.742349,"eighty":-0.537275,"marketCap":12403242},{"date":"2023-07-14","current":-0.553941,"twenty":-3.30433,"median":-0.735004,"eighty":-0.537275,"marketCap":11017878},{"date":"2023-07-21","current":-0.539113,"twenty":-3.30433,"median":-0.729628,"eighty":-0.536494,"marketCap":10722959},{"date":"2023-07-28","current":-0.481324,"twenty":-3.30433,"median":-0.724498,"eighty":-0.534659,"marketCap":9573530},{"date":"2023-08-04","current":-0.49425,"twenty":-3.30433,"median":-0.720134,"eighty":-0.53286,"marketCap":9830639},{"date":"2023-08-11","current":-0.53295,"twenty":-3.30433,"median":-0.717872,"eighty":-0.53227,"marketCap":10924412},{"date":"2023-08-18","current":-0.440744,"twenty":-3.30433,"median":-0.716071,"eighty":-0.531268,"marketCap":9034369},{"date":"2023-08-25","current":-0.436504,"twenty":-3.30433,"median":-0.714981,"eighty":-0.528148,"marketCap":8947451},{"date":"2023-09-01","current":-0.436504,"twenty":-3.30433,"median":-0.711312,"eighty":-0.523809,"marketCap":8947451},{"date":"2023-09-08","current":-0.422369,"twenty":-3.30433,"median":-0.709081,"eighty":-0.522306,"marketCap":8657724},{"date":"2023-09-15","current":-0.447479,"twenty":-3.30433,"median":-0.709081,"eighty":-0.517062,"marketCap":9172416},{"date":"2023-09-22","current":-0.430517,"twenty":-3.30433,"median":-0.709081,"eighty":-0.514706,"marketCap":8824743},{"date":"2023-09-29","current":-0.415801,"twenty":-3.305519,"median":-0.711004,"eighty":-0.51278,"marketCap":8523086},{"date":"2023-10-06","current":-0.407403,"twenty":-3.305519,"median":-0.705538,"eighty":-0.509488,"marketCap":8350954},{"date":"2023-10-13","current":-0.394932,"twenty":-3.305519,"median":-0.70319,"eighty":-0.508104,"marketCap":8095313},{"date":"2023-10-20","current":-0.374146,"twenty":-3.305519,"median":-0.70319,"eighty":-0.507081,"marketCap":7669244},{"date":"2023-10-27","current":-0.374146,"twenty":-3.31146,"median":-0.703469,"eighty":-0.505133,"marketCap":7669244},{"date":"2023-11-03","current":-0.374146,"twenty":-3.31146,"median":-0.703469,"eighty":-0.503666,"marketCap":7669244},{"date":"2023-11-10","current":-0.374146,"twenty":-3.31146,"median":-0.70319,"eighty":-0.501843,"marketCap":7669244},{"date":"2023-11-17","current":-0.351002,"twenty":-3.31146,"median":-0.697375,"eighty":-0.499296,"marketCap":6650086},{"date":"2023-11-24","current":-0.474857,"twenty":-3.31146,"median":-0.691269,"eighty":-0.497519,"marketCap":9169007},{"date":"2023-12-01","current":-0.528697,"twenty":-3.31146,"median":-0.684846,"eighty":-0.496211,"marketCap":10208616},{"date":"2023-12-08","current":-0.52958,"twenty":-3.307895,"median":-0.679746,"eighty":-0.496235,"marketCap":10225659},{"date":"2023-12-15","current":-0.518547,"twenty":-3.307895,"median":-0.675604,"eighty":-0.494662,"marketCap":10012624},{"date":"2023-12-22","current":-0.450143,"twenty":-3.307895,"median":-0.673813,"eighty":-0.494275,"marketCap":8691810},{"date":"2023-12-29","current":-0.390036,"twenty":-3.31146,"median":-0.671761,"eighty":-0.494091,"marketCap":7531197},{"date":"2024-01-05","current":-0.394272,"twenty":-3.315024,"median":-0.66912,"eighty":-0.493262,"marketCap":7613003},{"date":"2024-01-12","current":-0.370794,"twenty":-3.315024,"median":-0.668011,"eighty":-0.491925,"marketCap":7159665},{"date":"2024-01-19","current":-0.366293,"twenty":-3.318589,"median":-0.667779,"eighty":-0.490835,"marketCap":7072747},{"date":"2024-01-26","current":-0.372824,"twenty":-3.315024,"median":-0.664015,"eighty":-0.4874,"marketCap":7198863},{"date":"2024-02-02","current":-0.455086,"twenty":-3.315024,"median":-0.660462,"eighty":-0.48591,"marketCap":8787249},{"date":"2024-02-09","current":-0.472562,"twenty":-3.315024,"median":-0.658221,"eighty":-0.484311,"marketCap":9124696},{"date":"2024-02-16","current":-0.41572,"twenty":-3.315024,"median":-0.656727,"eighty":-0.483435,"marketCap":8027142},{"date":"2024-02-23","current":-0.433285,"twenty":-3.315024,"median":-0.655171,"eighty":-0.482634,"marketCap":8366293},{"date":"2024-03-01","current":-0.410424,"twenty":-3.31146,"median":-0.652353,"eighty":-0.480846,"marketCap":7924885},{"date":"2024-03-08","current":-0.406011,"twenty":-3.31146,"median":-0.649964,"eighty":-0.476369,"marketCap":7839671},{"date":"2024-03-15","current":-0.364616,"twenty":-3.31146,"median":-0.648423,"eighty":-0.474686,"marketCap":7040366},{"date":"2024-03-22","current":-0.443876,"twenty":-3.31146,"median":-0.645425,"eighty":-0.47327,"marketCap":8570806},{"date":"2024-03-28","current":-0.452789,"twenty":-3.31146,"median":-0.644454,"eighty":-0.471532,"marketCap":8308229},{"date":"2024-04-05","current":-0.401856,"twenty":-3.315024,"median":-0.641005,"eighty":-0.468806,"marketCap":7373661},{"date":"2024-04-12","current":-0.411202,"twenty":-3.315024,"median":-0.63863,"eighty":-0.465918,"marketCap":7545141},{"date":"2024-04-19","current":-0.418678,"twenty":-3.315024,"median":-0.636957,"eighty":-0.462258,"marketCap":7682325},{"date":"2024-04-26","current":-0.383119,"twenty":-3.31146,"median":-0.634914,"eighty":-0.458969,"marketCap":7029842},{"date":"2024-05-03","current":-0.390642,"twenty":-3.31146,"median":-0.632448,"eighty":-0.457367,"marketCap":7167884},{"date":"2024-05-10","current":-0.363932,"twenty":-3.31146,"median":-0.631649,"eighty":-0.455239,"marketCap":6927811},{"date":"2024-05-17","current":-0.336907,"twenty":-3.31146,"median":-0.627161,"eighty":-0.452468,"marketCap":6413370},{"date":"2024-05-24","current":-0.300421,"twenty":-3.31146,"median":-0.62339,"eighty":-0.450143,"marketCap":5718809},{"date":"2024-05-31","current":-0.242606,"twenty":-3.31146,"median":-0.62339,"eighty":-0.449152,"marketCap":4618241},{"date":"2024-06-07","current":-0.242787,"twenty":-3.31146,"median":-0.62339,"eighty":-0.446856,"marketCap":4621696},{"date":"2024-06-14","current":-0.218735,"twenty":-3.315024,"median":-0.623592,"eighty":-0.443857,"marketCap":4163846},{"date":"2024-06-21","current":-0.222547,"twenty":-3.318589,"median":-0.62339,"eighty":-0.441359,"marketCap":4236411},{"date":"2024-06-28","current":-0.220641,"twenty":-3.32857,"median":-0.625058,"eighty":-0.440638,"marketCap":4200128},{"date":"2024-07-05","current":-0.208752,"twenty":-3.32857,"median":-0.619265,"eighty":-0.43957,"marketCap":3973795},{"date":"2024-07-12","current":-0.23598,"twenty":-3.32857,"median":-0.616695,"eighty":-0.436682,"marketCap":4492116},{"date":"2024-07-15","current":-0.23598,"twenty":-3.32857,"median":-0.615556,"eighty":-0.436504,"marketCap":4492116},{"date":"2024-08-02","current":-0.198042,"twenty":-3.380136,"median":-0.617262,"eighty":-0.435015,"marketCap":3769922},{"date":"2024-08-09","current":-0.190599,"twenty":-3.380136,"median":-0.617262,"eighty":-0.432566,"marketCap":3628247},{"date":"2024-08-16","current":-0.154796,"twenty":-3.380136,"median":-0.617262,"eighty":-0.431604,"marketCap":3446835},{"date":"2024-08-23","current":-0.146835,"twenty":-3.380136,"median":-0.617262,"eighty":-0.430459,"marketCap":3269573},{"date":"2024-08-30","current":-0.212183,"twenty":-3.380136,"median":-0.617262,"eighty":-0.428972,"marketCap":4724670},{"date":"2024-09-06","current":-0.145368,"twenty":-3.380136,"median":-0.617262,"eighty":-0.427851,"marketCap":3236901},{"date":"2024-09-13","current":-0.162523,"twenty":-3.380136,"median":-0.617262,"eighty":-0.424552,"marketCap":3618896},{"date":"2024-09-20","current":-0.1711,"twenty":-3.380136,"median":-0.610449,"eighty":-0.423664,"marketCap":3809893},{"date":"2024-09-27","current":-0.124035,"twenty":-3.380136,"median":-0.610449,"eighty":-0.420134,"marketCap":2761878},{"date":"2024-10-04","current":-0.108834,"twenty":-3.380136,"median":-0.610449,"eighty":-0.418838,"marketCap":2423412},{"date":"2024-10-11","current":-0.159206,"twenty":-3.380136,"median":-0.610449,"eighty":-0.416624,"marketCap":3545040},{"date":"2024-10-18","current":-0.14798,"twenty":-3.380136,"median":-0.610449,"eighty":-0.415718,"marketCap":3295069},{"date":"2024-10-25","current":-0.153083,"twenty":-3.380136,"median":-0.610449,"eighty":-0.413435,"marketCap":3408693},{"date":"2024-10-31","current":-0.151042,"twenty":-3.380136,"median":-0.610449,"eighty":-0.411202,"marketCap":3363243},{"date":"2024-11-08","current":-0.220439,"twenty":-3.380374,"median":-0.611466,"eighty":-0.40952,"marketCap":4908517},{"date":"2024-11-15","current":-0.114938,"twenty":-3.380374,"median":-0.611466,"eighty":-0.407403,"marketCap":3067823},{"date":"2024-11-22","current":-0.125524,"twenty":-3.380374,"median":-0.611466,"eighty":-0.406011,"marketCap":3350351},{"date":"2024-11-29","current":-0.150115,"twenty":-3.380374,"median":-0.611466,"eighty":-0.405129,"marketCap":4006726},{"date":"2024-12-06","current":-0.134478,"twenty":-3.380374,"median":-0.611466,"eighty":-0.401856,"marketCap":3589359},{"date":"2024-12-13","current":-0.124054,"twenty":-3.380374,"median":-0.611466,"eighty":-0.398663,"marketCap":3311114},{"date":"2024-12-20","current":-0.119884,"twenty":-3.380374,"median":-0.611466,"eighty":-0.397185,"marketCap":3199816},{"date":"2024-12-27","current":-0.16471,"twenty":-3.380374,"median":-0.611466,"eighty":-0.396832,"marketCap":4396269},{"date":"2025-01-03","current":-0.172007,"twenty":-3.380374,"median":-0.611466,"eighty":-0.394932,"marketCap":4591040},{"date":"2025-01-10","current":-0.153243,"twenty":-3.381087,"median":-0.612657,"eighty":-0.392417,"marketCap":4090200},{"date":"2025-01-17","current":-0.149073,"twenty":-3.381087,"median":-0.612657,"eighty":-0.390751,"marketCap":3978902},{"date":"2025-01-24","current":-0.142818,"twenty":-3.381087,"median":-0.612657,"eighty":-0.389803,"marketCap":3811955},{"date":"2025-01-31","current":-0.133436,"twenty":-3.381087,"median":-0.612657,"eighty":-0.385763,"marketCap":3561534},{"date":"2025-02-07","current":-0.154285,"twenty":-3.381087,"median":-0.60887,"eighty":-0.382418,"marketCap":4118024},{"date":"2025-02-14","current":-0.179304,"twenty":-3.381087,"median":-0.607721,"eighty":-0.379483,"marketCap":4785812},{"date":"2025-02-21","current":-0.167837,"twenty":-3.381087,"median":-0.607721,"eighty":-0.376607,"marketCap":4479742},{"date":"2025-02-28","current":-0.145945,"twenty":-3.381087,"median":-0.607721,"eighty":-0.374146,"marketCap":3895428},{"date":"2025-03-07","current":-0.146988,"twenty":-3.3818,"median":-0.608308,"eighty":-0.373785,"marketCap":3923253},{"date":"2025-03-14","current":-0.120396,"twenty":-3.3818,"median":-0.608308,"eighty":-0.373039,"marketCap":3088518},{"date":"2025-03-21","current":-0.130158,"twenty":-3.3818,"median":-0.608308,"eighty":-0.373039,"marketCap":3338938},{"date":"2025-03-28","current":-0.131242,"twenty":-3.3818,"median":-0.608308,"eighty":-0.372688,"marketCap":3366763},{"date":"2025-04-04","current":-0.127989,"twenty":-3.3818,"median":-0.608308,"eighty":-0.372688,"marketCap":3283289},{"date":"2025-04-11","current":-0.126904,"twenty":-3.381087,"median":-0.607721,"eighty":-0.3724,"marketCap":3255465},{"date":"2025-04-17","current":-0.143195,"twenty":-3.381087,"median":-0.607721,"eighty":-0.370776,"marketCap":3673389},{"date":"2025-04-25","current":-0.153272,"twenty":-3.3818,"median":-0.608308,"eighty":-0.370706,"marketCap":3931878},{"date":"2025-05-02","current":-0.151851,"twenty":-3.3818,"median":-0.608308,"eighty":-0.366293,"marketCap":3895428},{"date":"2025-05-09","current":-0.069765,"twenty":-3.3818,"median":-0.608308,"eighty":-0.363401,"marketCap":1789671},{"date":"2025-05-16","current":-0.104097,"twenty":-3.3818,"median":-0.608308,"eighty":-0.357147,"marketCap":2582859},{"date":"2025-05-23","current":-0.089207,"twenty":-3.3818,"median":-0.608308,"eighty":-0.345815,"marketCap":2213401},{"date":"2025-05-30","current":-0.086956,"twenty":-3.3818,"median":-0.608308,"eighty":-0.336471,"marketCap":2157553},{"date":"2025-06-06","current":-0.155412,"twenty":-3.3818,"median":-0.608308,"eighty":-0.328428,"marketCap":3856071},{"date":"2025-06-13","current":-0.164848,"twenty":-3.3818,"median":-0.608308,"eighty":-0.307874,"marketCap":4090219},{"date":"2025-06-20","current":-0.148812,"twenty":-3.382513,"median":-0.607721,"eighty":-0.253225,"marketCap":3692332},{"date":"2025-06-27","current":-0.145249,"twenty":-3.382513,"median":-0.601576,"eighty":-0.23981,"marketCap":3603912},{"date":"2025-07-03","current":-0.161746,"twenty":-3.382513,"median":-0.592593,"eighty":-0.23598,"marketCap":4013243},{"date":"2025-07-11","current":-0.171641,"twenty":-3.382513,"median":-0.57922,"eighty":-0.227685,"marketCap":4258749},{"date":"2025-07-18","current":-0.17416,"twenty":-3.382513,"median":-0.575195,"eighty":-0.221331,"marketCap":4321253},{"date":"2025-07-25","current":-0.18033,"twenty":-3.382513,"median":-0.567502,"eighty":-0.218282,"marketCap":4474354},{"date":"2025-08-01","current":-0.162914,"twenty":-3.382513,"median":-0.563857,"eighty":-0.21025,"marketCap":4042229},{"date":"2025-08-08","current":-0.142395,"twenty":-3.382513,"median":-0.559832,"eighty":-0.201865,"marketCap":3533100},{"date":"2025-08-15","current":-0.141271,"twenty":-3.382513,"median":-0.552295,"eighty":-0.197588,"marketCap":4175109},{"date":"2025-08-22","current":-0.139484,"twenty":-3.382513,"median":-0.546449,"eighty":-0.189036,"marketCap":4122320},{"date":"2025-08-29","current":-0.134386,"twenty":-3.382513,"median":-0.540844,"eighty":-0.185506,"marketCap":3971632},{"date":"2025-09-05","current":-0.126721,"twenty":-3.383226,"median":-0.539113,"eighty":-0.183327,"marketCap":3745120},{"date":"2025-09-12","current":-0.136594,"twenty":-3.382513,"median":-0.536517,"eighty":-0.180793,"marketCap":4036898},{"date":"2025-09-19","current":-0.134158,"twenty":-3.382513,"median":-0.534056,"eighty":-0.178011,"marketCap":3964913},{"date":"2025-09-26","current":-0.126526,"twenty":-3.382513,"median":-0.53303,"eighty":-0.175763,"marketCap":3739362},{"date":"2025-10-03","current":-0.131852,"twenty":-3.382513,"median":-0.53227,"eighty":-0.172728,"marketCap":3896768},{"date":"2025-10-10","current":-0.15897,"twenty":-3.382513,"median":-0.53227,"eighty":-0.171412,"marketCap":4698197},{"date":"2025-10-17","current":-0.140004,"twenty":-3.382513,"median":-0.53227,"eighty":-0.170011,"marketCap":4137677},{"date":"2025-10-24","current":-0.111068,"twenty":-3.382513,"median":-0.53227,"eighty":-0.166945,"marketCap":3282499},{"date":"2025-10-31","current":-0.105222,"twenty":-3.382513,"median":-0.53227,"eighty":-0.163465,"marketCap":3109736},{"date":"2025-11-07","current":-0.088757,"twenty":-3.382513,"median":-0.53227,"eighty":-0.161746,"marketCap":2623120},{"date":"2025-11-14","current":-0.313947,"twenty":-3.382513,"median":-0.531784,"eighty":-0.161746,"marketCap":9278401},{"date":"2025-11-21","current":-0.276075,"twenty":-3.382513,"median":-0.52958,"eighty":-0.161746,"marketCap":7230405},{"date":"2025-11-28","current":-0.347703,"twenty":-3.382513,"median":-0.526633,"eighty":-0.161746,"marketCap":9106329},{"date":"2025-12-05","current":-0.311245,"twenty":-3.382513,"median":-0.522447,"eighty":-0.161746,"marketCap":8151497},{"date":"2025-12-12","current":-0.29965,"twenty":-3.382513,"median":-0.518527,"eighty":-0.161746,"marketCap":7847840},{"date":"2025-12-19","current":-0.225575,"twenty":-3.382513,"median":-0.514773,"eighty":-0.161746,"marketCap":5907811},{"date":"2025-12-26","current":-0.250696,"twenty":-3.382513,"median":-0.51073,"eighty":-0.161746,"marketCap":6565734},{"date":"2026-01-02","current":-0.271051,"twenty":-3.382513,"median":-0.509351,"eighty":-0.161746,"marketCap":7098820},{"date":"2026-01-09","current":-0.282645,"twenty":-3.382513,"median":-0.506297,"eighty":-0.161746,"marketCap":7402477},{"date":"2026-01-16","current":-0.282117,"twenty":-3.382513,"median":-0.503101,"eighty":-0.161746,"marketCap":7388656},{"date":"2026-01-23","current":-0.281709,"twenty":-3.382513,"median":-0.502006,"eighty":-0.161746,"marketCap":7377958},{"date":"2026-01-30","current":-0.253933,"twenty":-3.334273,"median":-0.494301,"eighty":-0.161746,"marketCap":6650504},{"date":"2026-02-06","current":-0.272178,"twenty":-3.252764,"median":-0.492695,"eighty":-0.161746,"marketCap":7128342},{"date":"2026-02-13","current":-0.245763,"twenty":-3.208088,"median":-0.491105,"eighty":-0.161746,"marketCap":6436546},{"date":"2026-02-20","current":-0.267821,"twenty":-3.135609,"median":-0.486305,"eighty":-0.161746,"marketCap":7014231},{"date":"2026-02-27","current":-0.268229,"twenty":-3.106609,"median":-0.484264,"eighty":-0.161746,"marketCap":7024929},{"date":"2026-03-06","current":-0.251074,"twenty":-3.065031,"median":-0.475167,"eighty":-0.161746,"marketCap":6575619},{"date":"2026-03-13","current":-0.349693,"twenty":-2.974254,"median":-0.470717,"eighty":-0.161746,"marketCap":8301358},{"date":"2026-03-20","current":-0.358805,"twenty":-2.93252,"median":-0.461346,"eighty":-0.161746,"marketCap":8517679},{"date":"2026-03-27","current":-0.432654,"twenty":-2.899148,"median":-0.457248,"eighty":-0.161746,"marketCap":10270779},{"date":"2026-04-02","current":-0.438067,"twenty":-2.887322,"median":-0.45206,"eighty":-0.161746,"marketCap":10399278},{"date":"2026-04-10","current":-0.497224,"twenty":-2.851634,"median":-0.450737,"eighty":-0.161746,"marketCap":11803594},{"date":"2026-04-17","current":-0.487751,"twenty":-2.82692,"median":-0.450143,"eighty":-0.161746,"marketCap":11578720},{"date":"2026-04-24","current":-0.736556,"twenty":-2.772306,"median":-0.450143,"eighty":-0.161746,"marketCap":17485106},{"date":"2026-05-01","current":-0.693252,"twenty":-2.734252,"median":-0.450143,"eighty":-0.161746,"marketCap":16457110},{"date":"2026-05-08","current":-0.769904,"twenty":-2.706558,"median":-0.450143,"eighty":-0.161746,"marketCap":16521360},{"date":"2026-05-15","current":-0.686497,"twenty":-2.646368,"median":-0.450143,"eighty":-0.161746,"marketCap":14731546},{"date":"2026-05-22","current":-0.634315,"twenty":-2.392511,"median":-0.450143,"eighty":-0.161746,"marketCap":13611765},{"date":"2026-05-29","current":-0.660834,"twenty":-2.280143,"median":-0.450143,"eighty":-0.161746,"marketCap":14180834},{"date":"2026-06-05","current":-0.60416,"twenty":-2.258363,"median":-0.450143,"eighty":-0.161746,"marketCap":12964678},{"date":"2026-06-12","current":-0.656557,"twenty":-2.206982,"median":-0.450143,"eighty":-0.161746,"marketCap":14089049},{"date":"2026-06-18","current":-0.577428,"twenty":-2.17461,"median":-0.450143,"eighty":-0.161746,"marketCap":12391020},{"date":"2026-06-26","current":-0.51113,"twenty":-2.11719,"median":-0.450143,"eighty":-0.161746,"marketCap":10968347},{"date":"2026-07-02","current":-0.535938,"twenty":-2.082937,"median":-0.450143,"eighty":-0.161746,"marketCap":11500702},{"date":"2026-07-10","current":-0.501507,"twenty":-1.979978,"median":-0.450143,"eighty":-0.161746,"marketCap":10761830},{"date":"2026-07-17","current":-0.488461,"twenty":-1.909689,"median":-0.450143,"eighty":-0.161746,"marketCap":10481885},{"date":"2026-07-24","current":-0.464081,"twenty":-1.679615,"median":-0.450143,"eighty":-0.161746,"marketCap":9958708},{"date":"2026-07-31","current":-0.449324,"twenty":-1.554283,"median":-0.448858,"eighty":-0.161746,"marketCap":9642049},{"date":"2026-08-07","current":-0.480762,"twenty":-1.435484,"median":-0.448751,"eighty":-0.161746,"marketCap":10316671},{"date":"2026-08-14","current":-0.908531,"twenty":-1.395884,"median":-0.448751,"eighty":-0.161746,"marketCap":10555313},{"date":"2026-08-21","current":-0.909321,"twenty":-1.363639,"median":-0.448751,"eighty":-0.161746,"marketCap":10564492}],"updateTime":1787576358366},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TOVX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659900699","title":"Inovio Q2 Net Loss Narrows on Warrant Gain, Lower Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900699","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900699?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:14","pubTimestamp":1786565676,"startTime":"0","endTime":"0","summary":"Inovio Q2 net loss narrows on warrant gain, lower costsOverviewUS biotech firm's Q2 net loss narrowed yr/yr, driven by non-cash warrant gainQ2 operating expenses fell due to lower compensation and dev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N449116:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX","BK4539","BK4583","UNCY","BK4568","INO","BK4139","GANX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659041419","title":"HC Wainwright Starts Theriva (TOVX) at Buy on Undervalued Oncolytic Virus Platform and Advancing VCN-01 Pancreatic Cancer Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2659041419","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659041419?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:55","pubTimestamp":1786557343,"startTime":"0","endTime":"0","summary":"Theriva Biologics, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCarthy from Maxim Group maintai...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/hc-wainwright-starts-theriva-tovx-at-buy-on-undervalued-oncolytic-virus-platform-and-advancing-vcn-01-pancreatic-cancer-program-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/hc-wainwright-starts-theriva-tovx-at-buy-on-undervalued-oncolytic-virus-platform-and-advancing-vcn-01-pancreatic-cancer-program-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","TOVX","LABU","BK4588","BK4585","XBI","BK4139","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658094581","title":"Cardiff Oncology Q2 Operating Expenses Fall on Lower R&D Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2658094581","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658094581?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:36","pubTimestamp":1786480574,"startTime":"0","endTime":"0","summary":"CORRECTED-Cardiff Oncology Q2 operating expenses fall on lower R&D costsCorrects to clarify second and third result drivers pertain to H1, not Q2OverviewUS biotech firm's Q2 operating expenses fell yr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N448110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","TOVX","BK4139","CRDF","BK4539","ERAS","PRLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658943113","title":"Bolt Biotherapeutics Q2 Net Loss Narrows on Restructuring and Lower Research Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2658943113","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658943113?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:24","pubTimestamp":1786479858,"startTime":"0","endTime":"0","summary":"Bolt Biotherapeutics Q2 net loss narrows on restructuring and lower research activityOverviewUS cancer immunotherapy developer's Q2 collaboration revenue fell sharply from prior yearNet loss narrowed ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480ZE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLT","PRLD","BK4505","TOVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658906919","title":"Theriva Biologics Q2 EPS $(0.07) Misses $(0.05) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658906919","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658906919?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:06","pubTimestamp":1786449994,"startTime":"0","endTime":"0","summary":"Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is a 96.37 percent increase over losses of $(1.93) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61105507/theriva-biologics-q2-eps-0-07-misses-0-05-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908129","title":"Theriva Biologics Q2 Net Income USD -3.217 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908129","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908129?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:01","pubTimestamp":1786449663,"startTime":"0","endTime":"0","summary":"BRIEF-Theriva Biologics Q2 Net Income USD -3.217 MillionAug 11 (Reuters) - Theriva Biologics Q2 income from operations USD -3.295 million.Q2 pretax profit USD -3.217 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLX0H76DJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658048997","title":"Theriva™ Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658048997","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658048997?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:00","pubTimestamp":1786449607,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA3B7Z9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658905209","title":"Theriva Biologics Q2 EPS USD -0.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2658905209","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658905209?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:00","pubTimestamp":1786449603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLX0H76DJ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990336","title":"Press Release: Theriva(TM) Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990336","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990336?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:00","pubTimestamp":1786449600,"startTime":"0","endTime":"0","summary":"Phase 2a clinical trial entitled \"A Phase IIa, single-arm, single-center,-- The VIRAGE2 study design incorporates feedback from both the. European Medicines Agency  and the U.S. Food and Drug. VIRAGE Phase 2b trial in metastatic PDAC patients treated with 2. repeated dosing of VCN-01 may provide additional clinical benefit.-- The VIRAGE2 trial will evaluate the safety and feasibility of. administering at least 3 doses of VCN-01 given approximately 2. The trial is expected to enroll 6 evaluable patients. Results from. the VIRAGE2 study will inform the VCN-01 dosing regimen for","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4555","BK4107","IDNA","L","LU2487616109.SGD","HYLG","03160","GDOC","MEDX","BK4081","TM","EMA","NVIB","BK4585","BK4139","LU0053666078.USD","BK4604","BK4588","TOVX","LU0210528500.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657263950","title":"Theriva Biologics Doses First Patient in Virage2 Phase 2a Trial of VCN-01 for Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2657263950","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657263950?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:13","pubTimestamp":1786018390,"startTime":"0","endTime":"0","summary":"Theriva Biologics doses first patient in VIRAGE2 Phase 2a trial of VCN-01 for metastatic pancreatic cancerTheriva Biologics began dosing in VIRAGE2, a Phase 2a trial testing more frequent repeat dosin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDLbh5VBx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656586115","title":"Theriva Biologics Holds Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2656586115","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656586115?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:21","pubTimestamp":1785842463,"startTime":"0","endTime":"0","summary":"Theriva Biologics holds annual shareholder meetingTheriva Biologics held its annual shareholder meeting on Aug. 3, 2026.Shareholders backed a change to the 2020 Stock Incentive Plan, raising the share","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDLJYkXC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649698781","title":"Theriva Biologics Wins Spanish Regulator Clearance for Virage2 Vcn-01 Pancreatic Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2649698781","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649698781?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:01","pubTimestamp":1783425687,"startTime":"0","endTime":"0","summary":"Theriva Biologics wins Spanish regulator clearance for VIRAGE2 VCN-01 pancreatic cancer trialTheriva Biologics received authorization from Spain’s AEMPS to start the VIRAGE2 Phase 2a trial of VCN-01 i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL9FL1Dt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","SG9999014039.USD","SG9999014013.SGD","IE00BKPKM429.USD","BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","TOVX","BK4112","NDAQ","BCDF","LU2095319765.USD","IE00BGHQF748.EUR","SG9999014021.USD","LU0314104364.USD","BK4139","IE00B3QW5Z07.USD","BK4585","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649982483","title":"Theriva™ Biologics Announces Regulatory Authorization to Proceed with a Virage2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of Vcn-01 (zabilugene Almadenorepvec) in First-line Patients with Metastatic Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2649982483","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649982483?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:00","pubTimestamp":1783425604,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA7Q4PSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642281190","title":"Theriva Biologics reports Phase 1 data showing VCN-01 plus durvalumab extends survival in refractory head and neck cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2642281190","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642281190?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:03","pubTimestamp":1781179385,"startTime":"0","endTime":"0","summary":"Theriva Biologics reported Phase 1 results for VCN-01 in metastatic, immunotherapy-refractory head and neck cancer, published online in Clinical Cancer Research.Results were already presented via publication, showing longer survival outcomes in heavily pretreated patients given VCN-01 before durvalumab.Translational findings supported the proposed mechanism, including tumor microenvironment changes consistent with improved immune activity and renewed sensitivity to durvalumab.Data favored sequential dosing over concomitant dosing, supporting further development of VCN-01 with checkpoint inhibitors in this setting.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL9vhFXW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4588","BK4139","IE00BN0W2T93.GBP","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014013.SGD","SG9999014005.SGD","BK4112","BK4585","LU0314104364.USD","IE00BN0W2V16.EUR","LU2095319765.USD","IE00BN0W2W23.USD","SG9999014039.USD","IE00BKPKM429.USD","TOVX","SG9999014021.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642328143","title":"Theriva Biologics - Median Overall Survival Reached 17.3 Months in Arm Ii Hd of Vcn-1 Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642328143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642328143?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:02","pubTimestamp":1781179363,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J0MR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642281139","title":"Theriva Biologics - Prolonged Overall Survival Observed in Refractory Hnscc Patients With Vcn-1 and Durvalumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2642281139","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642281139?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:02","pubTimestamp":1781179363,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J0MR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642158281","title":"Theriva™ Biologics Announces Results From Vcn-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2642158281","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642158281?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:02","pubTimestamp":1781179363,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J0MR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641140731","title":"Theriva Biologics Faces Quorum Issue Delaying Warrant Vote","url":"https://stock-news.laohu8.com/highlight/detail?id=2641140731","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641140731?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:56","pubTimestamp":1780693005,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Theriva Biologics ( ($TOVX) ). On June 5, 2026, Theriva Biologics, Inc. attempted to hold a Special Meeting of ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/theriva-biologics-faces-quorum-issue-delaying-warrant-vote?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/theriva-biologics-faces-quorum-issue-delaying-warrant-vote?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633818059","title":"Alliance Global Partners Sticks to Its Buy Rating for Theriva Biologics (TOVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633818059","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633818059?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:38","pubTimestamp":1778067507,"startTime":"0","endTime":"0","summary":"In a report released today, James Molloy from Alliance Global Partners reiterated a Buy rating on Theriva Biologics, with a price target of $4.00. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-sticks-to-its-buy-rating-for-theriva-biologics-tovx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-sticks-to-its-buy-rating-for-theriva-biologics-tovx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633922749","title":"Theriva Biologics Q1 FY26 net loss narrows to $2 million; revenue rises to $300,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2633922749","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633922749?lang=en_us&edition=fundamental","pubTime":"2026-05-06 05:09","pubTimestamp":1778015358,"startTime":"0","endTime":"0","summary":"Theriva Biologics posted a net loss attributable to common stockholders of USD 2.04 million, narrowing from USD 4.32 million a year earlier.Revenue was USD 300,000 versus no revenue a year earlier, while operating loss narrowed to USD 2.13 million from USD 4.42 million.Research and development expense fell 88% to USD 355,000, while general and administrative expense rose 43% to USD 2.07 million.Cash and cash equivalents rose to USD 14.4 million, with cash runway expected into Q1 2027.Management said it aligned with FDA on key elements of a Phase 3 VCN-01 trial design in metastatic pancreatic ductal adenocarcinoma, with a dosing-feasibility study expected to start at a single site in Spain in the second half of 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL85rrZs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4112","SG9999014039.USD","BK4585","BK4139","TOVX","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","SG9999014013.SGD","SG9999014005.SGD","NDAQ","IE00BN0W2V16.EUR","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014021.USD","LU0314104364.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}]}}